Trial Profile
For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 Dose of Certain Phase III Clinical Research
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Mycobacterium riyadhense (Primary)
- Indications Tuberculosis
- Focus Diagnostic use; Registrational
- Sponsors AnHui Longcom Biologic Pharmacy
- 10 Apr 2018 Planned number of patients changed from 1080 to 1090.
- 10 Apr 2018 Status changed from recruiting to completed.
- 12 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Apr 2018.